Asia Spotlight: Understanding Regs Key As CFDA Toughens GMP Enforcement
Executive Summary
The China FDA is substantially beefing up inspections of foreign drug manufacturing sites, showing assertiveness and confidence towards China's own GMP standards after a massive domestic campaign to root out quality violators. Staying out of trouble in the world's second largest pharma market will require keeping on top of local regulatory update.